MEGAN DEEDRICH: Open Payments
NPI 1003418138 · ST PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$447 in 21 payments from 8 companies in 2025. Trend: 2023 $248 · 2024 $638 · 2025 $447
Food & beverage: $447
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $153 |
| Novo Nordisk Inc | 8 | $143 |
| Amgen Inc. | 2 | $42 |
| GlaxoSmithKline, LLC. | 1 | $28 |
| Daiichi Sankyo Inc. | 1 | $25 |
| Boston Scientific Corporation | 1 | $25 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
Products named: QULIPTA, UBRELVY, Wegovy, Ozempic, TRELEGY ELLIPTA, KRYSTEXXA, INJECTAFER, WATCHMAN Access System.
Industry payments across FL — which companies pay providers there.
